Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Carlo Tanzi - Head of IR Eric Shaff - President & CEO Lisa von Moltke - Chief Medical Officer Matthew Henn - Chief Scientific Officer David Arkowitz - CFO Terri Young - Chief Commercial and Strategy Officer David Ege - Chief Technology Officer Conference Call Participants Mark Breidenbach - Oppenheimer Peyton Bohnsack - Cowen John Newman - Canaccord Ted Tenthoff - Piper Sandler Chris Howert ...